Patent · US Active

Ras inhibitors

US11739074B2 · kind B2 · utility

7Cited by
19References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2020
Grant dateAug 29, 2023
Priority date—
Expiry dateDec 20, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers. Exemplary Ras inhibitors include compounds of Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.